SCHEMBL2599211

SCHEMBL2599211

CCCCN(CCCC)CCCNC1=CC(=O)c2ncccc2C1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100A4 P26447 5/20 1.00
ALDH1A1 P00352 2/20 0.53
APAF1 O14727 2/20 0.53
MAPT P10636 2/20 0.50
MEN1 O00255 1/20 0.50
GUCY1B2 O75343 1/20 0.50
GUCY1A2 P33402 1/20 0.50
GUCY1A1 Q02108 1/20 0.50
GUCY1B1 Q02153 1/20 0.50
KMT2A Q03164 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
NSD2 O96028 5/20 0.49
TDP2 O95551 4/20 0.49
MALT1 Q9UDY8 1/20 0.44
NQO1 P15559 3/20 0.43
G6PD P11413 2/20 0.41
PAX8 Q06710 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2C8 P10632 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2599332 0.83 S100A4 (0.71) S100A4ALDH1A1APAF1MAPTMEN1
SCHEMBL10505442 0.82 S100A4 (0.70) S100A4ALDH1A1APAF1MAPTSMN1; SMN2
SCHEMBL458428 0.81 S100A4 (0.68) S100A4ALDH1A1APAF1MAPTMEN1
SCHEMBL8371686 0.79 S100A4 (0.65) S100A4ALDH1A1APAF1NSD2TDP2
SCHEMBL15698467 0.78 S100A4 (0.63) S100A4ALDH1A1APAF1MAPTMEN1
SCHEMBL18921849 0.75 MAPT (0.60) S100A4ALDH1A1APAF1MAPTMEN1
SCHEMBL10509896 0.73 KMT2A (0.58) S100A4ALDH1A1MAPTMEN1GUCY1B2
SCHEMBL12181932 0.73 S100A4 (1.00) S100A4ALDH1A1MAPTMEN1GUCY1B2
SCHEMBL7720493 0.73 S100A4 (0.57) S100A4ALDH1A1APAF1MAPTMEN1
SCHEMBL21814444 0.72 ALDH1A1 (0.79) S100A4ALDH1A1APAF1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130090355-A1 CHEMICAL AGENTS FOR THE PREVENTION OF INHIBITION OR TUMOR METASTASIS ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2013-04-11 US claimed
WO-2011146101-A1 CHEMICAL AGENTS FOR THE PREVENTION OR INHIBITION OF TUMOR METASTASIS ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2011-11-24 WO claimed
US-20130090355-A1 CHEMICAL AGENTS FOR THE PREVENTION OF INHIBITION OR TUMOR METASTASIS ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2013-04-11 US disclosed
US-20130090355-A1 CHEMICAL AGENTS FOR THE PREVENTION OF INHIBITION OR TUMOR METASTASIS ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2013-04-11 US disclosed
US-20130090355-A1 CHEMICAL AGENTS FOR THE PREVENTION OF INHIBITION OR TUMOR METASTASIS ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2013-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130090355-A1 CHEMICAL AGENTS FOR THE PREVENTION OF INHIBITION OR TUMOR METASTASIS S100A4, S100A6, S100A10 S100A4 1/4885ALDH1A1 2312/4885APAF1 1154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.